Position in XENE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$86,780,295
+$12,314,744 QoQ
Shares Held
1,437,712
+12.3% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 314 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. XENE ranks #22 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in XENE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,780,295 | 1,437,712 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $74,465,551 | 1,280,577 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $33,976,203 | 758,059 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $27,940,383 | 695,900 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $20,860,384 | 666,466 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $16,477,075 | 491,120 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,563,128 | 575,590 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $22,280,072 | 565,915 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $22,569,944 | 578,865 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,345,540 | 542,289 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $13,533,579 | 293,825 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $5,896,425 | 172,612 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,645,562 | 172,612 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,177,676 | 172,609 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||